Barclays PLC Xenon Pharmaceuticals Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Barclays PLC holds 14,993 shares of XENE stock, worth $583,227. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,993

Previous 14,993 -0.0%

Holding current value

$583,227

Previous $590,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$36.12 - $43.96 $502,176 - $611,175	13,903 Added 1275.5%	14,993 $590,000
Q2 2024 Aug 14, 2024	SELL	$36.25 - $43.75 $415,570 - $501,550	-11,464 Reduced 91.32%	1,090 $42,000
Q1 2024 May 15, 2024	SELL	$42.66 - $50.04 $4.24 Million - $4.98 Million	-99,436 Reduced 88.79%	12,554 $540,000
Q4 2023 Feb 15, 2024	BUY	$28.7 - $46.46 $2.94 Million - $4.76 Million	102,469 Added 1076.24%	111,990 $5.16 Million
Q3 2023 Nov 07, 2023	BUY	$34.16 - $39.73 $11,682 - $13,587	342 Added 3.73%	9,521 $324,000
Q2 2023 Aug 03, 2023	BUY	$34.84 - $43.54 $316,312 - $395,299	9,079 Added 9079.0%	9,179 $354,000
Q1 2023 May 04, 2023	BUY	$33.46 - $40.35 $3,346 - $4,035	100 New	100 $4,000
Q2 2022 Aug 12, 2022	SELL	$25.44 - $35.16 $4,859 - $6,715	-191 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$25.09 - $33.13 $4,792 - $6,327	191 New	191 $6,000
Q3 2021 Nov 09, 2021	SELL	$14.86 - $19.45 $594 - $778	-40 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$16.81 - $20.0 $2,387 - $2,840	-142 Reduced 78.02%	40 $1,000
Q1 2021 May 13, 2021	BUY	$13.65 - $21.31 $1,310 - $2,045	96 Added 111.63%	182 $3,000
Q4 2020 Feb 11, 2021	BUY	$9.49 - $16.04 $816 - $1,379	86 New	86 $1,000
Q1 2020 May 13, 2020	SELL	$8.08 - $17.57 $1,317 - $2,863	-163 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$8.11 - $14.65 $1,759 - $3,179	-217 Reduced 57.11%	163 $2,000
Q3 2019 Nov 14, 2019	BUY	$8.74 - $10.51 $3,321 - $3,993	380 New	380 $3,000
Q2 2019 Aug 14, 2019	SELL	$8.51 - $10.75 $17 - $21	-2 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$6.39 - $10.42 $23,802 - $38,814	-3,725 Reduced 99.95%	2 $0
Q4 2018 Feb 14, 2019	BUY	$5.61 - $12.62 $20,908 - $47,034	3,727 New	3,727 $24,000

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account